Effect of poly (ethylene glycol) molecular weight and microparticle size on oral insulin delivery from P(MAA-g-EG) microparticles

Drug Development and Industrial Pharmacy

Volumn 30, Issue 5, 2004, Pages 497-504

  López, Jennifer E ^a,b   Peppas, Nicholas A ^a  

^a The University of Texas at Austin   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

Controlled drug release; Oral insulin delivery; P(MAA g EG) microparticles; PEG; pH swelling behavior

Indexed keywords

COPOLYMER; INSULIN; MACROGOL; POLYMETHACRYLIC ACID DERIVATIVE;

ARTICLE; COMPLEX FORMATION; CONTROLLED DRUG RELEASE; DISSOCIATION; DRUG DELIVERY SYSTEM; FILM COATING; MOLECULAR WEIGHT; PARTICLE SIZE; PH; POLYMERIZATION; ULTRAVIOLET RADIATION;

ADMINISTRATION, ORAL; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; EXCIPIENTS; HYPOGLYCEMIC AGENTS; INSULIN; MOLECULAR WEIGHT; PARTICLE SIZE; POLYETHYLENE GLYCOLS; TECHNOLOGY, PHARMACEUTICAL;

EID: 1842868901     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.1081/DDC-120037480     Document Type: Article

References (46)

1. Fix, J.A. Oral controlled release technology for peptides: status and future prospects. Pharm. Res. 1996, 13, 1760-1764.
2. Bures, P.; Huang, Y.; Oral, E.; Peppas, N.A. Surface modifications and molecular imprinting of polymers in medical and pharmaceutical applications. J. Control. Release 2001, 72, 25-33.
3. Peppas, N.A.; Kim, B.S.; Donini, C.; Sipahigil, O.; Leobandung, W. Stimuli-sensitive polymers for oral and parenteral administration. In New Trends in Polymers for Oral and Parenteral Administration: From Design to Receptors; Barratt, G., Duchêne, D., Fattal, F., Legendre, J.Y., Eds.; Editions de Santé: Paris, 2001; 32-41.
4. Ichikawa, H.; Peppas, N.A. Synthesis and characterization of pH-responsive nanosized hydrogels of poly(methacrylic acid-g-ethylene glycol) for oral peptide delivery. In New Trends in Polymers for Oral and Parenteral Administration: From Design to Receptors; Barratt, G., Duchêne, D., Fattal, F., Legendre, J.Y., Eds.; Editions de Santé: Paris, 2001; 261-264.
5. Torres-Lugo, M.; Garcia, M.; Record, R.; Peppas, N.A. Physicochemical behavior and cytotoxic effects of P(MAA-g-EG) nanospheres for oral delivery of proteins. J. Control. Release 2002, 80, 197-205.
6. Carino, G.P.; Mathiowitz, E. Oral insulin delivery. Adv. Drug Deliv. Rev. 1999, 35, 249-257.
7. Parker, R.S.; Doyle, F.J., III; Peppas, N.A. A model-based algorithm for blood glucose control in type I diabetic patients. IEEE Trans. Biomed. Eng. 1999, 46, 148-157.
8. Parker, R.S.; Ward, J.H.; Doyle, F.J., III; Peppas, N.A. Robust control in diabetes using a physiological model. AIChE J. 2000, 46, 2537-2549.
9. Bell, C.L.; Peppas, N.A. Modulation of drug permeation through interpolymer complexed hydrogels for drug delivery applications. J. Control. Release 1996, 39, 201-207.
10. Lowman, A.M.; Peppas, N.A. Analysis of the complexation/decomplexation phenomena in graft copolymer networks. Macromolecules 1997, 30, 4959-4965.
11. Lowman, A.M.; Peppas, N.A. Molecular analysis of interpolymer complexation in graft copolymer networks. Polymer 2000, 41, 73-80.
12. Peppas, N.A.; Ichikawa, H.; Torres-Lugo, M. In Cytotoxicity and Transport Enhancement of Proteins Through Cell Monolayers Using Novel pH-Sensitive Hydrogels, Proceed. World Meeting APV/APGI, 2000; 201-202.
13. Garcia, M.; Torres-Lugo, M.; Alonso, M.J.; Peppas, N.A. Biointeractions of pH-sensitive poly(methacrylic acid-g-ethylene glycol) hydrogel microspheres with the Caco-2 model cell line. In New Trends in Polymers for Oral and Parenteral Administration: from Design to Receptors; Barratt, G., Duchêne, D., Fattal, F., Legendre, J.Y., Eds.; Editions de Santé: Paris, 2001; 386-389.
14. Morishita, M.; Lowman, A.M.; Takayama, K.; Nagai, T.; Peppas, N.A. Elucidation of the mechanism of incorporation of insulin in controlled release systems based on complexation polymers. J. Control. Release 2002, 81, 25-32.
15. Leobandung, W.; Ichikawa, H.; Fukumori, Y.; Peppas, N.A. Preparation of stable insulin-loaded nanospheres of poly(ethylene glycol) macromers and N-isopropyl acrylamide. J. Control. Release 2002, 80, 357-363.
16. Robinson, D.N.; Peppas, N.A. Preparation and characterization of pH-responsive poly(methacrylic acid-g-poly(ethylene glycol) nanospheres. Macromolecules 2002, 35, 3668-3674.
17. Torres-Lugo, M.; Peppas, N.A. Preparation and characterization of P(MAA-g-EG) nanospheres for protein delivery applications. J. Nanopart. Res. 2002, 4, 73-81.
18. Huang, Y.; Leobandung, W.; Foss, A.; Peppas, N.A. Molecular aspects of muco- and bioadhesion: tethered structures and site-specific surfaces. J. Control. Release 2000, 65, 63-71.
19. Huang, Y.; Efremova, N.; Peppas, N.A.; Leckband, D.E. Direct measurement of interactions between tethered PEG chains and adsorbed mucin layers. Langmuir 2002, 18, 836-845.
20. Madsen, F.; Peppas, N.A. Complexation graft copolymers networks: swelling properties calcium binding and proteolytic enzyme inhibition. Biomaterials 1999, 20, 1701-1708.
21. Foss, A.; Peppas, N.A. Investigation of the cytotoxicity and insulin transport of acrylic-based copolymer protein delivery systems in contact with Caco-2 cultures. Eur. J. Pharm. Biopharm. 2004, 57, 530-537.
22. Foss, A.C.; Goto, T.; Morishita, M.; Peppas, N.A. Development of acrylic-based copolymers for oral insulin delivery. J. Control. Release., Europ. J. Pharm. Biopharm. 2004, 57, 163-169.
23. Kim, B.; Peppas, N.A. Synthesis and characterization of pH-sensitive glycopolymers for oral drug delivery systems. J. Biomater. Sci., Polym. Ed. 2002, 13, 1271-1281.
24. Kim, B.; Peppas, N.A. Complexation phenomena in pH-responsive copolymer networks with pendent saccharides. Macromolecules 2002, 35, 9545-9550.
25. Lowman, A.L.; Morishita, M.; Kajita, M.; Nagai, T.; Peppas, N.A. Oral delivery of insulin using pH-responsive complexation gels. J. Pharm. Sci. 1999, 88, 933-937.
26. Elving, P.J.; Markowitz, J.M.; Rosenthal, I. Preparation of buffer systems of constant ionic strength. Anal. Chem. 1956, 28, 1179-1180.
27. Lowman, A.M.; Peppas, N.A. Pulsatile drug delivery based on a complexation/decomplexation mechanism. In Intelligent Materials for Controlled Release; Dinh, S.M., DeNuzzio, J.D., Comfort, A.R., Eds.; ACS Symposium Series: Washington, D.C., American Chemical Society (ACS), 1999; Vol. 728, 30-42.
28. Torres-Lugo, M.; Peppas, N.A. Molecular design and in vitro studies of novel pH-sensitive hydrogels for the oral delivery of calcitonin. Macromolecules 1999, 32, 6646-6651.
29. Leobandung, W.; Ichikawa, H.; Fukumori, Y.; Peppas, N.A. Monodisperse nanoparticles of poly(ethylene glycol) macromers and N-isopropyl acrylamide for biomedical applications. J. Appl. Polym. Sci. 2003, 87, 1678-1684.
30. Kavimandan, N.J.; Peppas, N.A. Insulin transport across cell monolayers in the presence of complexation hydrogels. Trans. Soc. Biomater. 2003, 29, 248.
31. Blanchette, J.; Park, K.; Peppas, N.A. Use of complexation hydrogels for oral administration of chemotherapeutic agents. Trans. Soc. Biomater. 2003, 29, 246.
32. Kim, B.; La Flamme, K.; Peppas, N.A. Dynamic swelling behavior of pH-sensitive anionic hydrogels used for protein delivery. J. Appl. Polym. Sci. 2003, 89, 1606-1613.
33. Kavimandan, N.J.; Peppas, N.A.; Morishita, M.; Goto, T.; Nagai, T.; Takayama, K. Experimental investigation of the effect of complexation hydrogels on insulin transport across model intestinal cell monolayers. Drug Deliv. Syst. 2003, 18, 283.
34. Morishita, M.; Goto, T.; Nagai, T.; Peppas, N.A.; Takayama, K. Development of oral insulin delivery systems and evaluation as pharmaceutical dosage forms in diabetic rats. Drug Deliv. Syst. 2003, 18, 282.
35. Kim, B.; Peppas, N.A. Analysis of molecular interactions in P(MAA-g-EG) hydrogels. Polymer 2003, 44, 3701-3707.
36. Kim, B.; Peppas, N.A. PEG-containing hydrogel microparticles for oral protein delivery applications. Biomed. Microdevices 2003, 5, 333-341.
37. Kim, B.; Peppas, N.A. In vitro release behavior and stability of insulin in complexation hydrogels as oral drug delivery carriers. Int. J. Pharm. 2003, 266, 29-37.
38. Ichikawa, H.; Peppas, N.A. Novel complexation hydrogels for oral peptide delivery: in vitro evaluation of their cytocompatibility and insulin-transport enhancing effects using Caco-2 cell monolayers. J. Biomed. Mater. Res. 2003, 67, 609-617.
39. Langer, R.; Peppas, N.A. Advances in biomaterials, drug delivery, and bionanotechnology. AIChE J. 2003, 49, 2990-3006.
40. Berger, J.; Reist, M.; Mayer, J.M.; Felt, O.; Peppas, N.A.; Gumy, R. Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications. Eur. J. Pharm. Biopharm. 2004, 57, 19-34.
41. Oral, E.; Peppas, N.A. Responsive and recognitive hydrogels using star polymers. J. Biomed. Mater. Res. 2004, 68A, 439-447.
42. López, J.E.; Peppas, N.A. Cellular evaluation of insulin transmucosal delivery. J. Biomater. Sci., Polym. Ed. 2004, 15, 385-396.
43. Peppas, N.A. Kinetics of smart hydrogels. In Reflexive Polymers and Hydrogels: Understanding and Designing Fast-Responsive Polymeric Systems; Yui, N., Mrsny, R., Park, K., Eds.; CRC Press, 2004; 99-114.
44. Nakamura, K.; Murray, R.J.; Joseph, J.I.; Peppas, N.A.; Morishita, M.; Lowman, A.M. Oral insulin delivery using P(MAA-g-EG) hydrogels: effects of network morphology on insulin delivery characteristics. J. Control. Release, 2004, 95, 589-599.
45. Lowman, A.M.; Dziubla, T.D.; Bures, P.; Peppas, N.A. Structural and dynamic response of neutral and intelligent networks in biomedical environments. In Molecular and Cellular Foundations of Biomaterials; Peppas, N.A., Sefton, M.V., Eds.; Academic Press: New York, 2004; 75-130.
46. Morishita, M.; Goto, T.; Peppas, N.A.; Joseph, J.I.; Torjman, M.C.; Munsick, C.; Nakamura, K.; Takayama, K.; Lowman, A.M. Mucosal insulin delivery systems based on complexation polymer hydrogels: effect of particle size on insulin enteral absorption. J. Control. Release, 2004, in press.